CAROCOVATEIN
UNII 2V3ZF46GMQ

Substance Identification & Data

This profile provides standardized clinical and technical data for Carocovatein, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2V3ZF46GMQ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2762666-72-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
2V3ZF46GMQ
CAS Registry Number
2762666-72-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
CAROCOVATEIN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
12615
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Carocovatein. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CAROCOVATEIN

Common Names & Synonyms

1-1195-SPIKE GLYCOPROTEIN (669-GLYCINE,670-SERINE,672-SERINE,973-PROLINE,974-PROLINE) (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2) FUSION PROTEIN WITH FIBRITIN (ENTEROBACTERIA PHAGE T4 TRIMERIZATION MOTIF (FOLDON)) FUSION PROTEIN WITH PEPTIDE LINKER (GRS) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC HRV-3C CLEAVAGE SITE), TRIMER
CAROCOVATEIN [INN]